News
Resonance Health News - June 2017
- 30 June 2017
We are excited to release our second newsletter of the calender year, in what has been an extremely busy period here at Resonance Health. We look forward to sharing further information and welcome your ongoing participation.
To view the newsletter please click here...
Uncertainty over Serum Ferritin in Cancer Survivors
- 23 June 2017
There is increasing recognition that paediatric cancer survivors are at risk of transfusion-related iron overload caused by their intensive treatment regimes. The results of a recent study demonstrate problems with the current screening method (serum ferritin) for iron overload in this field. Resonance Health’s FerriScan® technology, the globally recognised gold standard for the assessment of iron overload, is ideally positioned as a reliable, non-invasive alternative.
TIF MEDIA RELEASE & CLINICAL ALERT
- 21 June 2017
The Thalassaemia International Federation (TIF) has released a Media Release and Clinical Alert to warn of the potential dangers of an unsafe MRI ‘T2*’ technique used widely for the assessment of iron overload and the critical need to use validated techniques such as FerriScan.
Conference Round-up
- 08 June 2017
Our team has had a busy few months with attendance across six key conferences worldwide.
FerriScan® Results Are Not Confounded by Liver Fat
- 19 April 2017
Recent study results have demonstrated that FerriScan, the globally recognised gold standard for the measurement of liver iron concentration (LIC), is not confounded by the presence of liver steatosis. This places FerriScan at a distinct advantage to alternative magnetic resonance imaging (MRI) LIC assessment techniques, such as liver T2*, whose results are impacted by the presence of fat due to the inherent nature of the technique.
Resonance Health News - March 2017
- 31 March 2017
We are delighted to release our first newsletter of the calender year, in what has already been a very busy start to 2017. We look forward to further progressing in our endeavours and welcome your ongoing participation.
To view the newsletter please click here...